1. Postbiotic Supplements - Overview
1.1.Definitions and Scope
2. Postbiotic Supplements - Executive Summary
3. Postbiotic Supplements - Comparative Analysis
3.1.Company Benchmarking - Key Companies
3.2.Global Financial Analysis - Key Companies
3.3.Market Share Analysis - Key Companies
3.4.Patent Analysis
3.5.Pricing Analysis
4. Postbiotic Supplements - Start-up Companies Scenario
4.1.Key Start-up Company Analysis by
4.2.Investment
4.3.Revenue
4.4.Venture Capital and Funding Scenario
5. Postbiotic Supplements – Market Entry Scenario Premium
5.1.Regulatory Framework Overview
5.2.New Business and Ease of Doing Business Index
5.3.Case Studies of Successful Ventures
6. Postbiotic Supplements - Forces
6.1.Market Drivers
6.2.Market Constraints
6.3.Market Challenges
6.4.Porter's Five Force Model
6.5.Bargaining Power of Suppliers
6.6.Bargaining Powers of Customers
6.7.Threat of New Entrants
6.8.Rivalry Among Existing Players
6.9.hreat of Substitutes
7. Postbiotic Supplements – Strategic Analysis
7.1.Value Chain Analysis
7.2.Opportunities Analysis
7.3.Market Life Cycle
8. Postbiotic Supplements – By Form (Market Size – $Million/$Billion)
8.1. Powder
8.1.1.Market Size and Forecast, By Region
8.1.2.Market Share Analysis, By Country
8.2. Capsules
8.2.1.Market Size and Forecast, By Region
8.2.2.Market Share Analysis, By Country
8.3. Liquid
8.3.1.Market Size and Forecast, By Region
8.3.2.Market Share Analysis, By Country
8.4. Tablets
8.4.1.Market Size and Forecast, By Region
8.4.2.Market Share Analysis, By Country
8.5. Others
8.5.1.Market Size and Forecast, By Region
8.5.2.Market Share Analysis, By Country
9. Postbiotic Supplements – BY Type (Market Size – $Million/$Billion)
9.1. Short-chain fatty acids
9.1.1.Market Size and Forecast, By Region
9.1.2.Market Share Analysis, By Country
9.2 Lipopolysaccharides
9.2.1.Market Size and Forecast, By Region
9.2.2.Market Share Analysis, By Country
9.3. Muramly dipeptide
9.3.1.Market Size and Forecast, By Region
9.3.2.Market Share Analysis, By Country
9.4. P40 molecule
9.4.1.Market Size and Forecast, By Region
9.4.2.Market Share Analysis, By Country
10. Postbiotic Supplements – By Distribution Channel (Market Size – $Million/$Billion)
10.1. Online Retail
10.1.1.Market Size and Forecast, By Region
10.1.2.Market Share Analysis, By Country
10.2. Supermarkets/Hypermarkets
10.2.1.Market Size and Forecast, By Region
10.2.2.Market Share Analysis, By Country
10.3. Drug Stores
10.3.1.Market Size and Forecast, By Region
10.3.2.Market Share Analysis, By Country
11. Postbiotic Supplements – by Geography (Market Size – $Million/$Billion)
11.1.North America
11.1.1.The U.S.
11.1.2.Canada
11.1.3.Mexico
11.2.Europe
11.2.1.UK
11.2.2.Germany
11.2.3.France
11.2.4.Italy
11.2.5.Spain
11.2.6.Russia
11.2.7.Rest of Europe
11.3.Asia-Pacific
11.3.1.China
11.3.2.India
11.3.3.Japan
11.3.4.South Korea
11.3.5.Australia & New Zealand
11.3.6.Rest of Asia-Pacific
11.4.South America
11.4.1.Brazil
11.4.2.Argentina
11.4.3.Chile
11.4.4.Colombia
11.4.5.Rest of South America
11.5.Rest of the World
11.5.1.Middle East
11.5.2.Africa
12. Postbiotic Supplements – Entropy
13. Postbiotic Supplements – Industry/Segment Competition Landscape
13.1.Market Share Analysis
13.1.1.Market Share by Product Type – Key Companies
13.1.2.Market Share by Region – Key Companies
13.1.3.Market Share by Country – Key Companies
13.2.Competition Matrix
13.3.Best Practices for Companies
14. Postbiotic Supplements – Key Company List by Country Premium
15. Postbiotic Supplements - Company Analysis
- Seed Health
- Sun Genomics
- Viome
- 4D Pharma
- BioGaia
- Thorne
- Nutrasal
- UAS Labs
- Postbiotia
- Postbiotics Plus
- Postbiotix
- The Gut Company
- DuPont Nutrition & Biosciences
- Metagenics
- Amazentis
- NutraLife Biosciences
- Dr. Ohhira's Probiotics
- CoreBiome
- NextFerm Technologies
- Symbiome